申请人:Frequency Therapeutics, Inc.
公开号:US20200316089A1
公开(公告)日:2020-10-08
The present disclosure relates to 1,2-dihydro-3H-pyrazol-3-one compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into tissue cells.
本公开涉及1,2-二氢-3H-吡唑-3-酮化合物及其使用方法,用于诱导干/祖细胞支持细胞的自我更新,包括诱导干/祖细胞增殖,同时维持子细胞中分化成组织细胞的能力。